These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7486911)

  • 1. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    Chavanet P; Beloeil H; Pechinot A; Duigou F; Buisson JC; Duong M; Neuwirth C; Kazmierczak A; Portier H
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1736-43. PubMed ID: 7486911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    Chavanet P; Peyrard N; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2062-66. PubMed ID: 8878581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    Chavanet P; Champliaud D; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
    J Antimicrob Chemother; 1996 Oct; 38(4):655-70. PubMed ID: 8937960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
    Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
    Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
    J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
    Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
    Bañón Arias R; García López M; Pinedo Sánchez A
    J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.
    Chavanet P; Muggeo E; Waldner A; Dijoux S; Caillot D; Portier H
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):271-5. PubMed ID: 2351143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    Barry B; Muffat-Joly M; Bauchet J; Faurisson F; Gehanno P; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1977-82. PubMed ID: 8878566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
    Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
    J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.